# A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE

> **NCT02824484** · NA · COMPLETED · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 250 (actual)

## Conditions studied

- Breast Cancer
- Colorectal Cancer

## Interventions

- **BEHAVIORAL:** GWDP
- **BEHAVIORAL:** Control

## Key facts

- **NCT ID:** NCT02824484
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2019-11-18
- **Final completion:** 2021-12-31
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2025-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02824484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02824484, "A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02824484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*